Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edvard Smith

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Nucleic Acid Therapeutics|March 3, 2022
2'-<i>O</i>-(<i>N</i>-(Aminoethyl)carbamoyl)methyl Modification Allows for Lower Phosphorothioate Content in Splice-Switching Oligonucleotides with Retained ActivityDmytro Honcharenko, Cristina S J Rocha, Karin E Lundin, et al.
Journal of Human Immunity|May 22, 2026
Novel molecular assays for monitoring T cell function after HSCT in two siblings with variants in <i>DCLRE1C</i>Anna Lyytikäinen, Yasaman Shamshirgaran, Hedvig Hjerpe, et al.
Nucleic Acids Research|March 24, 2017
CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expressionEman M Zaghloul, Olof Gissberg, Pedro M D Moreno, et al.
Molecular Therapy. Nucleic Acids|January 7, 2025
Anti-gene oligonucleotide clamps invade dsDNA and downregulate <i>huntingtin</i> expressionTea Umek, Karin E Lundin, Metoboroghene O Mowoe, et al.
Advanced Healthcare Materials|November 13, 2021
Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular VesiclesJeremy P Bost, Osama Saher, Daniel Hagey, et al.
Pharmaceutics|January 22, 2021
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching OligonucleotidesHaneen Daralnakhla, Osama Saher, Susanna Zamolo, et al.
Plos One|May 17, 2012
Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cellsRami Genead, Helene Fischer, Alamdar Hussain, et al.
Nucleic Acid Therapeutics|February 3, 2023
Chemical Modifications and Design Influence the Potency of <i>Huntingtin</i> Anti-Gene OligonucleotidesOsama Saher, Eman M Zaghloul, Tea Umek, et al.
Nucleic Acids Research|September 24, 2010
Optimizing anti-gene oligonucleotide 'Zorro-LNA' for improved strand invasion into duplex DNAEman M Zaghloul, Andreas S Madsen, Pedro M D Moreno, et al.
Human Molecular Genetics|September 20, 2015
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restorationThomas C Roberts, Henrik J Johansson, Graham McClorey, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Nucleic Acid Therapeutics|March 3, 2022
2'-<i>O</i>-(<i>N</i>-(Aminoethyl)carbamoyl)methyl Modification Allows for Lower Phosphorothioate Content in Splice-Switching Oligonucleotides with Retained ActivityDmytro Honcharenko, Cristina S J Rocha, Karin E Lundin, et al.
Journal of Human Immunity|May 22, 2026
Novel molecular assays for monitoring T cell function after HSCT in two siblings with variants in <i>DCLRE1C</i>Anna Lyytikäinen, Yasaman Shamshirgaran, Hedvig Hjerpe, et al.
Nucleic Acids Research|March 24, 2017
CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expressionEman M Zaghloul, Olof Gissberg, Pedro M D Moreno, et al.
Molecular Therapy. Nucleic Acids|January 7, 2025
Anti-gene oligonucleotide clamps invade dsDNA and downregulate <i>huntingtin</i> expressionTea Umek, Karin E Lundin, Metoboroghene O Mowoe, et al.
Advanced Healthcare Materials|November 13, 2021
Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular VesiclesJeremy P Bost, Osama Saher, Daniel Hagey, et al.
Pharmaceutics|January 22, 2021
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching OligonucleotidesHaneen Daralnakhla, Osama Saher, Susanna Zamolo, et al.
Plos One|May 17, 2012
Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cellsRami Genead, Helene Fischer, Alamdar Hussain, et al.
Nucleic Acid Therapeutics|February 3, 2023
Chemical Modifications and Design Influence the Potency of <i>Huntingtin</i> Anti-Gene OligonucleotidesOsama Saher, Eman M Zaghloul, Tea Umek, et al.
Nucleic Acids Research|September 24, 2010
Optimizing anti-gene oligonucleotide 'Zorro-LNA' for improved strand invasion into duplex DNAEman M Zaghloul, Andreas S Madsen, Pedro M D Moreno, et al.
Human Molecular Genetics|September 20, 2015
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restorationThomas C Roberts, Henrik J Johansson, Graham McClorey, et al.
Pageof 18